| Abstract: | Dynorphin and other kappa opioid agonists are thought to elicit aversive actions and changes in motor activity through direct or indirect modulation of dopamine neurons in ventral tegmental area (VTA) and substantia nigra (SN), respectively. We comparatively examined the immunoperoxidase localization of anti-dynorphin A antiserum in sections through the VTA and SN of adult rat brain to assess whether there were common or differential distributions of this opioid peptide relative to the dopamine neurons. We also more directly examined the relationship between dynorphin terminals and dopamine neurons in VTA and SN by combining immunoperoxidase labeling of rabbit dynorphin antiserum and immunogold-silver detection of mouse antibodies against tyrosine hydroxylase (TH) in single sections through the VTA and SN. Light microscopy showed dynorphin-like immunoreactivity (DY-LI) in varicose processes. These were relatively sparse in VTA and were unevenly distributed in the SN, with little labeling in the pars compacta (pcSN) and the highest density of DY-LI in the medial and lateral pars reticulata (prSN). Electron microscopy established that the regional differences were attributed to differences in density (number/unit area) of immunoreactive profiles. The profiles containing DY-LI were designated as axon terminals based on having diameters greater than 0.1 μm, few microtubules and many synaptic vesicles. In both the VTA and SN, the dynorphin-labeled terminals contained primarily small (35–40 nm) clear vesicles. These vesicles were rimmed with peroxidase immunoreactivity and were often seen clustered above axodendritic synapses. These synaptic specializations were usually symmetric; however a few asymmetric densities also were formed by immunoreactive terminals in both VTA and SN. Additionally, most of the dynorphin-labeled terminals contained 1–2, but occasionally 7 or more intensely peroxidase positive dense core vesicles (DCVs). Approximately 60% of the DCVs were located near axolemmal surfaces. The axolemmal surfaces contacted by immunoreactive DCVs were more often apposed to dendrites in the VTA; while in the SN other axon terminals were the most commonly apposed neuronal profiles. In both regions, a substantial proportion of the plasmalemmal surface in contact with the labeled DCVs was apposed to astrocytic processes. In dually labeled sections through the VTA, 22% (n = 138) of the terminals containing DY-LI formed synapseson or were apposed to TH-labeled dendrites, while 16% were in contact with unlabeled dendrites. The remainder were apposed to other dynorphin labeled and unlabeled terminals and/or astrocytes. In dually labeled sections through the prSN, 37% (n = 216) of the terminals containing DY-LI formed synapses or were apposed to TH-labeled dendrites, while 28% contacted unlabeled dendrites. The remainder were in contact with axon terminals or astrocytes. These findings demonstrate the morphologically heterogeneous terminals containing DY-LI in rat VTA and SN provide a substantial monosynaptic input to dopamine and non-dopamine targets. The finding of symmetric and asymmetric synapses, mixed vesicle populations, and associations with dendrites, terminals, and astrocytes suggests multiple sites for dynorphin actions in both VTA and SN. |
